Home

Tango Therapeutics, Inc.

CIK 1819133 · last filed 2021-12-10

Tango Therapeutics, Inc. is a corporate insider who has filed 1 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing, for BPMC, was dated Dec 10, 2021. The firm reports its address in Boston, MA. 48 SEC filings were submitted jointly with Third Rock Ventures IV, L.P.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

1

Lifetime Open-Market Net

$0

Filer Profile

Reported Address
201 BROOKLINE AVENUE
SUITE 901
BOSTON, MA 02215
Phone
(857) 320-4900
State of Incorporation
DE
Formerly Known As
BCTG Acquisition Corp. (2020–2021)
Related Filers
Third Rock Ventures IV, L.P. — 48 joint filings, latest 2026-02-10
Adam Crystal — 22 joint filings, latest 2026-08-05
TRV GP IV, LLC — 19 joint filings, latest 2025-10-27
Third Rock Ventures GP IV, L.P. — 19 joint filings, latest 2025-10-27
Aaron I. Davis — 16 joint filings, latest 2024-11-07
MVA Investors, LLC — 14 joint filings, latest 2024-07-02
Daniella Beckman — 11 joint filings, latest 2026-06-11
BCTG Holdings, LLC — 10 joint filings, latest 2025-01-02
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Blueprint Medicines Corp (BPMC) Delisted Director 3,400 $129.46 $440.2K $0 1 2021-12-10

Recent Filings

1 filing
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2021-12-10 Blueprint Medicines Corp (BPMC) Delisted Grant (A) +3,400 $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.